Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioMarin Appoints Arpit Davé Chief Digital and Information Officer PR Newswire - Mon Jan 12, 3:05PM CST

Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical Industry

BMRN : 54.59 (-0.87%)
APPN
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky StockStory - Thu Jan 8, 10:35PM CST

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

APPN : 28.62 (-3.51%)
PVH : 64.63 (-4.38%)
BMRN : 54.59 (-0.87%)
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA PR Newswire - Thu Jan 8, 3:05PM CST

SAN RAFAEL, Calif. , Jan. 8, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present...

BMRN : 54.59 (-0.87%)
Veeva and BioMarin Form Long-Term Strategic Partnership PR Newswire - Thu Jan 8, 7:30AM CST

Partnership to help BioMarin increase speed and efficiency  in developing and commercializing innovative therapies

VEEV : 222.21 (+1.49%)
BMRN : 54.59 (-0.87%)
Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD Business Wire - Fri Dec 26, 2025

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Amicus Therapeutics...

FOLD : 14.33 (+0.14%)
BMRN : 54.59 (-0.87%)
BMRN
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know StockStory - Tue Dec 23, 2025

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

BMRN : 54.59 (-0.87%)
3d illustration inflation and deflation graph by Deepadesigns via Shutterstock
A $4.8 Billion Reason to Buy BioMarin Stock Today Barchart - Mon Dec 22, 2025

BioMarin stock soars as the biotech firm announces a $4.8 billion acquisition of Amicus Therapeutics. The transaction could push BMRN shares even higher in 2026.

FOLD : 14.33 (+0.14%)
BMRN : 54.59 (-0.87%)
BMRN
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today StockStory - Fri Dec 19, 2025

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

BMRN : 54.59 (-0.87%)
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook PR Newswire - Fri Dec 19, 2025

BioMarin to Gain Galafold ® (migalastat) for Fabry Disease and Pombiliti ® (cipaglucosidase alfa-atga) + Opfolda ® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth...

FOLD : 14.33 (+0.14%)
BMRN : 54.59 (-0.87%)
CHD
1 Oversold Stock Primed to Rebound and 2 That Underwhelm StockStory - Mon Dec 15, 2025

1 Oversold Stock Primed to Rebound and 2 That Underwhelm

SHW : 357.83 (+0.48%)
BMRN : 54.59 (-0.87%)
CHD : 90.61 (+0.20%)

Barchart Exclusives

As Apple Teams Up with Google on Siri AI Upgrades, Should You Buy AAPL Stock? Barchart - 3 minutes ago
Apple’s decision to tap Google’s Gemini AI to supercharge Siri is redefining its AI strategy. Is AAPL a buy now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot